vorherige Seite8 of 12nächste Seite
Management Report
Management Report

Calculation of EBIT(DA) Before Special Items

Key performance indicators for the Bayer Group are EBIT before special items, EBITDA before special items and the EBITDA margin before special items. These indicators are reported in order to allow a more accurate assessment of business operations. The special items – one-time effects that are non-recurring or do not regularly recur or attain similar magnitudes – are detailed in the following table. “EBITDA,” “EBITDA before special items” and “EBIT before special items” are not defined in the International Financial Reporting Standards and should therefore be regarded only as supplementary information. The company considers EBITDA before special items to be a more suitable indicator of operating performance since it is not affected by depreciation, amortization, write-downs/write-backs or special items. The company also believes that this indicator gives readers a clearer picture of the results of operations and ensures greater comparability of data over time. The EBITDA margin before special items, which is the ratio of EBITDA before special items to sales, serves as a relative indicator for the internal and external comparison of operational earning power.
Depreciation and amortization in the first quarter of 2009 was slightly below the previous year at €688 million (-3.4%), comprising €378 million in amortization and write-downs of intangible assets and €310 million in depreciation and write-downs of property, plant and equipment. Of the included write-downs, €10 million constituted special items.


Special Items Reconciliation
EBIT*
1st Quarter
2008
EBIT*
1st Quarter
2009
EBITDA**
1st Quarter
2008
EBITDA**
1st Quarter
2009
 € million€ million€ million€ million
After special items1,343 973 2,055 1,661
HealthCare100 18 80 18
Schering PPA effects***51 0 51 0
Schering integration costs49 18 29 18
CropScience54 8 50 4
Restructuring54 8 50 4
MaterialScience0 18 0 12
Restructuring0 18 0 12
Total special items154 44 130 34
Before special items1,497 1,017 2,185 1,695

* EBIT as per income statements

** EBITDA: EBIT plus amortization of intangible assets and depreciation of property, plant and equipment.

*** The purchase price paid for Schering AG, Germany, was allocated among the acquired assets and assumed liabilities in accordance with the International Financial Reporting Standards (IFRS). To ensure comparability with future earnings data, the expected long-term effects of the step-up are reflected in EBIT and EBITDA before special items, whereas temporary, non-cash effects of the purchase price allocation are eliminated and deducted when calculating EBIT before special items.

top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
Print page
Search
Search
Advanced Search
Download Center
 
 
Links
Annual Report 2008
 
Financial Reports
 
Comparison
Services
Order print version
 
Event Reminder
 
Press Newsletter
 
Would you like to be kept informed about new financial reports from Bayer?
 
SMS Service
Calendar
Investor Conference Call
 
Annual Stockholders' Meeting 2009
Info
Notes on our information package and all services